	Kısa Vadeli Yükümlülükler		Tarih
AbbVie	USD 43.29B	3.9B	2025-12
Amgen	USD 25.49B	3.7B	2025-12
Anika Therapeutics	USD 19.09M	3.01M	2025-09
Arrowhead Research	USD 347.42M	151.94M	2025-12
AstraZeneca	USD 30.62B	3.44B	2025-12
BioCryst Pharmaceuticals	USD 190.24M	13.08M	2025-09
Biogen	USD 3.35B	59.4M	2025-12
Bristol-Myers Squibb	USD 28.14B	608M	2025-09
Enanta Pharmaceuticals	USD 44.73M	3.83M	2025-12
Gilead Sciences	USD 11.81B	485M	2025-12
GlaxoSmithKline	GBP 21.39B	57M	2025-12
Halozyme Therapeutics	USD 177.09M	660.14M	2025-12
Heron Therapeutics	USD 89.71M	168.89M	2025-09
Immunic	USD 30.08M	2.77M	2025-09
Incyte	USD 1.52B	176.44M	2025-12
Insmed	USD 468.87M	51.66M	2025-12
Ionis Pharmaceuticals	USD 783M	120.46M	2025-12
J&J	USD 54.13B	3.26B	2025-12
Karyopharm Therapeutics	USD 87.16M	12.06M	2025-09
Ligand Pharmaceuticals	USD 37.45M	6.91M	2025-12
Merck	USD 28.63B	2.59B	2025-09
Neurocrine Biosciences	USD 743.4M	105.4M	2025-12
Novartis	USD 32B	286M	2025-09
Novavax	USD 429.87M	40.73M	2025-09
Pfizer	USD 36.6B	1.13B	2025-09
PTC Therapeutics	USD 968.43M	102.18M	2025-12
Roche Holding	CHF 28B	421M	2025-12
Sarepta Therapeutics	USD 1.1B	173.86M	2025-12
Vertex Pharmaceuticals	USD 3.86B	614.1M	2025-12

Enanta Pharmaceuticals Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2026.